Priya Raina joined AnaptysBio in July 2022 with 20 years of experience in various roles in Clinical Operations advancing complex clinical programs in autoimmune diseases, oncology, and stem cell research. Prior to joining AnaptysBio, Priya was the head of the clinical operations department at Amarin Pharma and Ichnos Sciences and held positions of increasing responsibility at Mesoblast Inc, Novartis, and IQVIA. Priya earned her undergraduate degree from Columbia University in Biomedical Engineering and Master’s Degree in Biotechnology from University of Pennsylvania.